A biotechnology drug developer focused on treatments for cancer, immune disorders, and inflammatory diseases. Its portfolio historically included blockbuster therapies such as Revlimid and Pomalyst for blood cancers, making the company a major player in oncology drug markets. Investors closely follo...
4 members of Congress have disclosed 8 trades in Celgene Corporation (CELG), a Healthcare company. The buy/sell breakdown shows 6 purchases versus 2 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2014-03-06 | David P. Roe | buy | $1K – $15K |
| 2014-02-14 | MICHAEL T. MCCAUL | sell | $15K – $50K |
| 2014-01-31 | David P. Roe | buy | $1K – $15K |
| 2014-01-30 | Susan M Collins | sell | $1K – $15K |
| 2014-01-23 | David P. Roe | buy | $1K – $15K |
| 2014-01-23 | David P. Roe | buy | $1K – $15K |
| 2014-01-23 | David P. Roe | buy | $1K – $15K |
| 2014-01-17 | K. Michael Conaway | buy | $1K – $15K |